[DOI] [PMC free article] [PubMed] [Google Scholar] 37.Day JW, Gelfanov V, Smiley D, Carrington PE, Eiermann G, Chicchi G, Erion MD, Gidda J, Thornberry NA, Tschp MH, Marsh DJ, SinhaRoy R, DiMarchi R, Pocai A
We dont know yet if it is better or worse, Jay says
Neither is yet available in the UK, where MHRA approval is still pending for both
A skipped dose does far more damage to your weight loss results than choosing a slightly less optimal injection site ever could
Todays Sources: Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists Comparison of the efficacy and safety of 10 glucagon-like peptide-1 GLP-1 diabetes and weight-loss drug side effects - Harvard Health Ozempic Could Crush the Junk Food Industry